D-0625-2026 Class I Ongoing
FDA drug recall D-0625-2026 was initiated by CareFusion 213, LLC on May 28, 2026 and is designated Class I. Reason for recall: Non-Sterility: Due to presence of Aspergillus penicillioides. And Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area. The recall status is ongoing. Affected quantity: 178,000 applicators.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 1, 2026
- Initiation Date
- May 28, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 178,000 applicators
Product description
BD ChloraPrep FREPP Clear,(2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)) 1.5 mL Applicator, 20 Applicators, Sterile Solution, Care Fusion 213, LLC, El Paso, TX 79912, subsidiary of Beckton, Dickinson and Co., NDC 54365-400-30.
Reason for recall
Non-Sterility: Due to presence of Aspergillus penicillioides. And Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area.
Distribution pattern
Nationwide inthe USA, as well as other foreign distribution.
Code information
Lot # 4073005, Exp 03/31/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0625-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026